Eisai Co., Ltd. et al v. Lupin Limited et al

Plaintiff: Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant: Lupin Pharmaceuticals, Inc. and Lupin Limited
Case Number: 1:2019cv01336
Filed: July 17, 2019
Court: US District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35:271
Jury Demanded By: None

Docket Report

This docket was last retrieved on July 17, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 17, 2019 Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 7/17/2019; Lupin Pharmaceuticals, Inc. on 7/17/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd)
July 17, 2019 Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (kmd)
July 17, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Corporation of North America, Corporate Parent Eisai Co., Ltd. for Eisai Co., Ltd., Eisai Inc. filed by Eisai Co., Ltd., Eisai Inc.. (kmd)
July 17, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (kmd)
July 17, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/25/2019. Date of Expiration of Patent: 5/14/2023.Thirty Month Stay Deadline: 12/25/2021. (kmd)
July 17, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
July 17, 2019 Filing 1 COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2687974.) - filed by Novartis Pharma AG, Eisai Co., Ltd., Eisai Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) Modified on 7/17/2019 (kmd).

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Eisai Co., Ltd. et al v. Lupin Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharma AG
Represented By: Anthony David Raucci
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Eisai Inc.
Represented By: Anthony David Raucci
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Eisai Co., Ltd.
Represented By: Anthony David Raucci
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lupin Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?